218 related articles for article (PubMed ID: 24806669)
1. A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models.
Kallop DY; Meilandt WJ; Gogineni A; Easley-Neal C; Wu T; Jubb AM; Yaylaoglu M; Shamloo M; Tessier-Lavigne M; Scearce-Levie K; Weimer RM
J Neurosci; 2014 May; 34(19):6425-37. PubMed ID: 24806669
[TBL] [Abstract][Full Text] [Related]
2. Beta amyloid-induced upregulation of death receptor 6 accelerates the toxic effect of N-terminal fragment of amyloid precursor protein.
Xu Y; Wang D; Luo Y; Li W; Shan Y; Tan X; Zhu C
Neurobiol Aging; 2015 Jan; 36(1):157-68. PubMed ID: 25150572
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.
Masliah E; Xie F; Dayan S; Rockenstein E; Mante M; Adame A; Patrick CM; Chan AF; Zheng B
Neuroscience; 2010 Aug; 169(1):488-94. PubMed ID: 20433905
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of β-secretase.
Olsen O; Kallop DY; McLaughlin T; Huntwork-Rodriguez S; Wu Z; Duggan CD; Simon DJ; Lu Y; Easley-Neal C; Takeda K; Hass PE; Jaworski A; O'Leary DD; Weimer RM; Tessier-Lavigne M
J Neurosci; 2014 May; 34(19):6438-47. PubMed ID: 24806670
[TBL] [Abstract][Full Text] [Related]
5. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.
Nikolaev A; McLaughlin T; O'Leary DD; Tessier-Lavigne M
Nature; 2009 Feb; 457(7232):981-9. PubMed ID: 19225519
[TBL] [Abstract][Full Text] [Related]
6. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
[TBL] [Abstract][Full Text] [Related]
7. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein (APP) regulates synaptic structure and function.
Tyan SH; Shih AY; Walsh JJ; Maruyama H; Sarsoza F; Ku L; Eggert S; Hof PR; Koo EH; Dickstein DL
Mol Cell Neurosci; 2012 Aug; 51(1-2):43-52. PubMed ID: 22884903
[TBL] [Abstract][Full Text] [Related]
9. The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
Klevanski M; Herrmann U; Weyer SW; Fol R; Cartier N; Wolfer DP; Caldwell JH; Korte M; Müller UC
J Neurosci; 2015 Dec; 35(49):16018-33. PubMed ID: 26658856
[TBL] [Abstract][Full Text] [Related]
10. Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
Fowler SW; Chiang AC; Savjani RR; Larson ME; Sherman MA; Schuler DR; Cirrito JR; Lesné SE; Jankowsky JL
J Neurosci; 2014 Jun; 34(23):7871-85. PubMed ID: 24899710
[TBL] [Abstract][Full Text] [Related]
11. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.
Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R
Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
[TBL] [Abstract][Full Text] [Related]
14. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
15. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
16. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
17. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
18. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
[TBL] [Abstract][Full Text] [Related]
19. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
20. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
